Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of oral and intravenous lipid load on Hepatitis C virus concentrations
2011-002351-34Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2012
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Intralipid 10% in hepatitis C virus infection, sponsored by Medical University of Vienna. Primary endpoint: Changes in serum HCV-RNA and HCVVLDF after oral or intravenous fat load. Started Oct 2012; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-002351-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002351-34.